The Role of the Ketogenic Diet in Lung Cancer: Current Evidence and Future Perspectives
Cancers · 17.04.2026 · 18 (8) · 1279
DOI: 10.3390/cancers18081279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.04.2026. Verfasst von Eleni D Eleftheriadou und 10 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Pulmonary Department, General Hospital of Thessaloniki "G. Papanikolaou", Leoforos Papanikolaou Municipality of Chortiatis, 57010 Thessaloniki, G…. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Lung cancer (LC) remains the leading cause of cancer-related death worldwide, despite advances in systemic and targeted therapies. A mechanism of survival of tumor cells is metabolic reprogramming, characterized by increased glucose uptake, aerobic glycolysis, and alterations in mitochondrial function. These adaptations seem to support tumor growth, immune evasion, and therapeutic resistance. In parallel, supportive care and specifically nutritional interventions have become essential components of modern oncology. The interplay between metabolic reprogramming and targeted nutritional strategies represents a promising area of investigation that bridges tumor biology with supportive care, aiming to enhance both therapeutic efficacy and patient quality of life.
Methods
This narrative review explores the biological and pathophysiological rationale for the ketogenic diet (KD) as a possible complementary intervention in LC management and summarizes the published preclinical and clinical data supporting this rationale.
Results
We discuss key aspects of tumor metabolism, including the Warburg effect, glucose dependency, oxidative stress regulation, fatty acid metabolism, lactate cycling and tumor microenvironment interactions, with particular emphasis on how carbohydrate restriction and ketosis may exacerbate mitochondrial dysfunction in cancer cells and modulate inflammatory pathways. Furthermore, we summarize available preclinical and clinical evidence evaluating the KD in oncology and, more specifically, in LC, focusing on feasibility, safety, metabolic effects, and potential synergy with chemotherapy, radiotherapy, and immunotherapy.
Conclusions
While preclinical models suggest enhanced treatment efficacy, clinical data remain limited and heterogeneous, with patient adherence representing a major challenge. Further well-designed longitudinal studies are required to clarify the therapeutic role of the ketogenic diet in lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Pulmonary Department, General Hospital of Thessaloniki "G. Papanikolaou", Leoforos Papanikolaou Municipality of Chortiatis, 57010 Thessaloniki, Greece.
- Adult ICU, General Hospital of Thessaloniki "Ippokrateio", Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
- Immunonutrition Unit, Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41223 Larissa, Greece.
- Department of Nutrition and Dietetics Sciences, Hellenic Mediterranean University, 72300 Sitia, Greece.
- 2nd Propedeutic Department of Internal Medicine, General Hospital of Thessaloniki "Ippokrateio", Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
- Respiratory Failure Clinic and Sleep Laboratory, General Hospital of Thessaloniki "G. Papanikolaou", Aristotle's University of Thessaloniki, Leoforos Papanikolaou Municipality of Chortiatis, 57010 Thessaloniki, Greece.
ORCID-Profile: Eleni D Eleftheriadou, Serafeim-Chrysovalantis Kotoulas, Maria G Grammatikopoulou, Paschalis Evangelidis, Anastasios Vamvakis, Athanasia Pataka, Dionisios Spyratos
Zitieren
APA
Eleftheriadou, E. D., Kotoulas, S. C., Grammatikopoulou, M. G., Karakousi, A., Maria, A., Trimpali, A., Tsalampounis, X., Evangelidis, P., Vamvakis, A., Pataka, A., & Spyratos, D. (2026). The Role of the Ketogenic Diet in Lung Cancer: Current Evidence and Future Perspectives. Cancers, 18(8), 1279. https://doi.org/10.3390/cancers18081279
Vancouver
Eleftheriadou ED, Kotoulas SC, Grammatikopoulou MG, Karakousi A, Maria A, Trimpali A, et al. The Role of the Ketogenic Diet in Lung Cancer: Current Evidence and Future Perspectives. Cancers. 2026;18(8):1279. doi:10.3390/cancers18081279
BibTeX
@article{Eleftheriadou2026,
author = {Eleftheriadou, Eleni D and Kotoulas, Serafeim-Chrysovalantis and Grammatikopoulou, Maria G and Karakousi, Anna and Maria, Azoidou and Trimpali, Aikaterini and Tsalampounis, Xenofon and Evangelidis, Paschalis and Vamvakis, Anastasios and Pataka, Athanasia and Spyratos, Dionisios},
title = {The Role of the Ketogenic Diet in Lung Cancer: Current Evidence and Future Perspectives},
journal = {Cancers},
year = {2026},
volume = {18},
number = {8},
pages = {1279},
doi = {10.3390/cancers18081279}
}
EUVIMED